期刊
ISCIENCE
卷 2, 期 -, 页码 88-+出版社
CELL PRESS
DOI: 10.1016/j.isci.2018.03.010
关键词
-
资金
- Experimental Pathology of Cardiovascular Disease, NIH [T32 HL007312]
- University of Washington's Proteomics Resource [UWPR95794]
- NIH [U01 HL100405, P01 GM081619, R01 HL084642, P01 HL094374]
- Foundation Leducq Transatlantic Network of Excellence
Cardiac development requires coordinated biphasic regulation of the WNT/beta-catenin signaling pathway. By intersecting gene expression and loss-of-function siRNA screens we identified Alpha Protein Kinase 2 (ALPK2) as a candidate negative regulator of WNT/beta-catenin signaling in cardiogenesis. In differentiating human embryonic stem cells (hESCs), ALPK2 is highly induced as hESCs transition from mesoderm to cardiac progenitors. Using antisense knockdown and CRISPR/Cas9 mutagenesis in hESCs and zebrafish, we demonstrate that ALPK2 promotes cardiac function and cardiomyocyte differentiation. Quantitative phosphoproteomics, protein expression profiling, and beta-catenin reporter assays demonstrate that loss of ALPK2 led to stabilization of beta-catenin and increased WNT signaling. Furthermore, cardiac defects attributed to ALPK2 depletion can be rescued in a dose-dependent manner by direct inhibition of WNT signaling through the small molecule XAV939. Together, these results demonstrate that ALPK2 regulates beta-catenin-dependent signaling during developmental commitment of cardiomyocytes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据